Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?-Reference-Cited by-同舟云学术

Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?

Published:2023-03-02 Issue:5 Volume:15 Page:1561
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Said Medhat M.¹²^ORCID,Broen Martinus P. G.³⁴^ORCID,Swart Eleonora L.¹²^ORCID,Bartelink Imke H.¹²^ORCID,Kouwenhoven Mathilde C. M.²⁵^ORCID

Affiliation:

1. Department of Pharmacy & Clinical Pharmacology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands

2. Cancer Treatment and Quality of Life, Cancer Center Amsterdam, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands

3. Department of Neurology, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands

4. GROW-School for Oncology and Reproduction, Maastricht University, 6229 ER Maastricht, The Netherlands

5. Department of Neurology, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands

Abstract

Glioblastoma multiforme is the most common primary central nervous system tumor, with an incidence of 3 [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/15/5/1561/pdf

Reference41 articles.

1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018;Ostrom;Neuro-Oncology,2021

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma;Stupp;N. Engl. J. Med.,2005

3. MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma;Hegi;N. Engl. J. Med.,2005

4. Temozolomide-Related Idiosyncratic and Other Uncommon Toxicities: A Systematic Review;Dixit;Anticancer. Drugs,2012

5. Prognostic Significance of Therapy-Induced Myelosuppression in Newly Diagnosed Glioblastoma;Oppong;Neuro-Oncology,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-acting therapeutic delivery systems for the treatment of gliomas;Advanced Drug Delivery Reviews;2023-06